Two Sigma Advisers’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-63,300
Closed -$960K 2646
2019
Q4
$960K Sell
63,300
-16,200
-20% -$140K ﹤0.01% 1595
2019
Q3
$508K Sell
79,500
-88,000
-53% -$735K ﹤0.01% 1705
2019
Q2
$1.6M Buy
167,500
+43,300
+35% +$466K ﹤0.01% 1311
2019
Q1
$1.68M Buy
124,200
+8,800
+8% +$73.4K ﹤0.01% 1296
2018
Q4
$830K Sell
115,400
-75,200
-39% -$823K ﹤0.01% 1572
2018
Q3
$2.08M Sell
190,600
-19,000
-9% -$192K 0.01% 1212
2018
Q2
$1.93M Buy
209,600
+138,700
+196% +$1.29M 0.01% 1316
2018
Q1
$566K Buy
70,900
+62,900
+786% +$1.37M ﹤0.01% 1769
2017
Q4
$222K Buy
+8,000
New +$212K ﹤0.01% 2057
2016
Q4
Sell
-24,600
Closed -$832K 2502
2016
Q3
$832K Buy
24,600
+9,500
+63% +$306K ﹤0.01% 1446
2016
Q2
$442K Buy
+15,100
New +$417K ﹤0.01% 1571

Two Sigma Advisers's DERM Position: Q1 2020 in Review

Two Sigma Advisers sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 63,300 shares — an estimated $960K sold.

Two Sigma Advisers first reported a position in DERM in Q2 2016 and held it in 11 quarters. The position peaked at $2.08M in Q3 2018. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • Two Sigma Advisers reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 63,300 Dermira, Inc. shares in Q1 2020, an estimated $960K.
  • Two Sigma Advisers first reported a position in Dermira, Inc. in Q2 2016 and held it in 11 quarters.
  • Two Sigma Advisers's Dermira, Inc. position peaked at $2.08M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Two Sigma Advisers's 13F filing for Q1 2020, filed 15 May 2020.